OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Multitargeting HDAC Inhibitors Containing a RAS/RAF Protein Interfering Unit
Yuanjiang Wang, Jianluo Zhang, Kun Li, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 2066-2082
Closed Access | Times Cited: 8
Yuanjiang Wang, Jianluo Zhang, Kun Li, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 2066-2082
Closed Access | Times Cited: 8
Showing 8 citing articles:
Synthesis and biological evaluation of the Fluoro analog of Romidepsin with improved selectivity for class I histone deacetylases (HDACs)
Xinluo Song, Hanqi Wang, Ya Gao, et al.
Bioorganic Chemistry (2025) Vol. 159, pp. 108348-108348
Closed Access
Xinluo Song, Hanqi Wang, Ya Gao, et al.
Bioorganic Chemistry (2025) Vol. 159, pp. 108348-108348
Closed Access
Radical-mediated sulfonylation relay of alkyl alkynes/alkenes and electron-deficient alkenes to access vinyl and alkyl sulfones
Jinhui Liu, Fang Long, Qing Li, et al.
Organic Chemistry Frontiers (2025)
Closed Access
Jinhui Liu, Fang Long, Qing Li, et al.
Organic Chemistry Frontiers (2025)
Closed Access
Small molecules targeting HDAC6 for cancer treatment: Current progress and novel strategies
Ziqian Huang, Ling Li, Binbin Cheng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117218-117218
Open Access | Times Cited: 3
Ziqian Huang, Ling Li, Binbin Cheng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117218-117218
Open Access | Times Cited: 3
Design and Synthesis of c-Met and HDAC Dual Inhibitors for the Treatment of Breast Cancer
Zuoyang Wang, Zhichao Shi, Shiqi Yang, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 9, pp. 1516-1525
Closed Access | Times Cited: 1
Zuoyang Wang, Zhichao Shi, Shiqi Yang, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 9, pp. 1516-1525
Closed Access | Times Cited: 1
Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor Immunity
Churu Mao, Jiebin Fang, Shijie Zou, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 22, pp. 20619-20638
Closed Access | Times Cited: 1
Churu Mao, Jiebin Fang, Shijie Zou, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 22, pp. 20619-20638
Closed Access | Times Cited: 1
Design and Synthesis of C-Mesenchymal Epithelial Transition Factor (C-Met) and Histone Deacetylase (Hdac) Dual Inhibitors for the Treatment of Breast Cancer
Zuoyang Wang, Zhichao Shi, Zizhou Niu, et al.
(2024)
Closed Access
Zuoyang Wang, Zhichao Shi, Zizhou Niu, et al.
(2024)
Closed Access
Discovery of dual-targeted molecules based on Olaparib and Rigosertib for triple-negative breast cancer with wild-type BRCA
Zhikun Liu, Shining Mao, Lumei Dai, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 113, pp. 117936-117936
Closed Access
Zhikun Liu, Shining Mao, Lumei Dai, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 113, pp. 117936-117936
Closed Access
Diversified applications and synthesis of hydroxamic acids
Yao Li, Junzhou Li, Chun Cai, et al.
Australian Journal of Chemistry (2024) Vol. 77, Iss. 12
Closed Access
Yao Li, Junzhou Li, Chun Cai, et al.
Australian Journal of Chemistry (2024) Vol. 77, Iss. 12
Closed Access
